comprehensive
WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies.
Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary, ProvideGx, with the same aim.
advertisement
Although shortages are not new, the number of drugs in short supply has grown steadily for about two years. Shortages also have become more difficult to predict and are affecting drugs that are more critical.
Get unlimited access to award-winning journalism and exclusive events.
Subscribe Log In
Previous article：
Pfizer is about to make a big push in cancer. Will investors listen?
Next article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： BioMarin wins approval for gene therapy to treat hemophilia A
